---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-007863"
form_type: "8-K"
ticker: "AGL"
cik: "0001831097"
company_name: "agilon health, inc."
filed_at: "2022-05-05T23:59:59+00:00"
generated_at: "2026-06-25T23:58:52.402909+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# agilon health Q1 revenue up 58% to $653M, net income $1M, guides FY2022 revenue $2.5-2.6B

## Summary
- Revenue $653M (+58% YoY); normalized revenue growth 49%. Net income $1M vs $15M loss.
- Medical margin $86M (+66% YoY), representing 13.2% of revenue (vs 12.6%).
- Adjusted EBITDA $12M, up from $4M last year.
- Medicare Advantage members 250,000 (+51% YoY); same geography +20%.
- FY2022 guidance: revenue $2,505-2,590M, medical margin $290-305M, adjusted EBITDA $0-10M.

## SEC filing metadata
- accession: 0000950170-22-007863
- form_type: 8-K
- ticker: AGL
- cik: 0001831097
- company_name: agilon health, inc.
- filed_at: 2022-05-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831097/000095017022007863/0000950170-22-007863-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831097/000095017022007863/agl-20220505.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-007863
- JSON: https://secwatch.observer/filing/0000950170-22-007863.json
- Plain text: https://secwatch.observer/filing/0000950170-22-007863.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
